Factors Affecting Immediate Anterior Implants: Retrospective Clinical Study
Summary
The NIH ClinicalTrials.gov registry has posted a retrospective cohort study (NCT07539168) evaluating clinical, surgical, and prosthetic factors associated with outcomes of immediate implant placement in the anterior maxilla. The observational study aims to identify predictors of implant survival and complications within 12 months of placement, and will assess peri-implant marginal bone loss, prosthetic complications, and esthetic outcomes using the pink esthetic score.
“This retrospective cohort study evaluates clinical, surgical, and prosthetic factors associated with early and mid-term outcomes of immediate implant placement in the anterior maxilla.”
What changed
A retrospective observational cohort study (NCT07539168) titled 'Factors Affecting Immediate Anterior Implants' has been registered on ClinicalTrials.gov under NIH. The study evaluates immediate implant placement in the anterior maxilla and tracks primary outcomes including implant survival, infection, soft-tissue dehiscence, and esthetic failure within 12 months, alongside secondary assessments of marginal bone loss and pink esthetic scores.
This study registration does not create compliance obligations and is informational in nature. Healthcare providers and clinical investigators conducting implant research may find the findings relevant to future clinical practice guidelines and informed consent documentation.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Factors Affecting Immediate Anterior Implants. Reterosepective Clinical Study
Observational NCT07539168 Kind: OBSERVATIONAL Apr 20, 2026
Abstract
This retrospective cohort study evaluates clinical, surgical, and prosthetic factors associated with early and mid-term outcomes of immediate implant placement in the anterior maxilla. The primary objective is to identify predictors of implant survival and complications (e.g., infection, soft-tissue dehiscence, esthetic failure) within 12 months following placement. Secondary objectives include assessment of peri-implant marginal bone loss, prosthetic complications, and esthetic outcomes (pink esthetic score).
Conditions: Pink Esthetic Score, Implant Survival Rate, Immediate Implant Placement
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.